Pharmacy Track
The health system pharmacy plays a vital role in patient outcomes and IDN pharmacy executives continue to look for innovative methods of improving quality while keeping costs low.  The problems facing the pharmacy segment of healthcare are complex and include maintaining compliance with a myriad of changing regulations while attempting to keep up with increased demand.  The Pharmacy Track will have two distinct themes at the Spring IDN Summit.  Theme 1 is Important Actions to Mitigate Revenue Loss.  Topics covered will include the 2018 OPPS Rule, the biosimilar drug landscape, product shortages and reducing drug spend. 
Theme 2 is Retooling Pharmacy Operations.  Discussion will be centered around innovations and trends including using a Pharmacy consolidated services center, best practices for managing costs in ambulatory practices, and specialty pharmacies.
THEME 1:  Important Actions to Mitigate Revenue Loss
Monday, April 16, 2018
1:00 PM - 1:40 PM
National Ballroom D
The 2018 OPPS final rule, effective January 1, 2018, will drastically reduce payments for drugs purchased under the 340B drug discount program.  This policy will have a significant financial impact on hospitals and will add potential regulatory burden as well. This presentation will delve into what's needed to get paid for a drug, where the information comes from and who will be responsible for ensuring accuracy and completeness of data being submitted.  A cross functional multidisciplinary approach to revenue cycle management is essential with expensive specialty drugs commanding a larger percentage of the drug spend and payors competing with clinicians for control of that spend. 2018 OPPS 340B payments and newly proposed legislation also will be discussed.
Learning Objectives:
1. Describe the recent modifications to the 340B drug discount program.
2. Outline the challenges that 340B presents for hospital pharmacy executives.
3. Detail methods of driving savings as a result of the 340B program.
Bonnie Kirschenbaum MS, FASHP, FCSHP
Consultant, Columnist

Monday, April 16, 2018
1:40 PM - 2:15 PM
National Ballroom D
Biologics have revolutionized the way we manage and treat patients with conditions including cancer, rheumatic, neurologic and gastrointestinal diseases. Biosimilars are biologic agents that are designed to mimic the properties of branded biologics (known as reference products). Biosimilars have potential to produce significant health care cost savings in the United States and improve patient access to treatment options. This session will provide pharmacists an approach to developing use strategies to incorporate biosimilars into daily practice.  
Learning Objectives:
1. Explain the benefits that biosimilars may provide to patients, payers and providers.
2. Evaluate clinical practice implications for pharmacists surrounding biosimilar use with a focus on agents used in gastrointestinal and rheumatic diseases.
3. Recognize core knowledge and skillset needed to prepare pharmacists to incorporate biosimilar use routinely into clinical practice.



Jessica Farrell PharmD
Clinical Pharmacist/Associate Professor
Albany College of Pharmacy and Health Sciences & The Center for Rheumatology

Monday, April 16, 2018
2:30 PM - 3:10 PM
National Ballroom D
As health systems seek new sources of revenue and means for improving performance under value-based payment, some are turning to an unlikely source: their own pharmacies. Pharmacies look to unleash their ability to manage chronic disease, reduce readmissions through rigorous medication reconciliation while a patient is in the hospital, and help keep patients from returning to the hospital.  Drug price hyperinflation has hit the U.S., with annual price increases of 20% or more. If for no other reason, pharmacy needs to help slow spending on drugs.  Discover steps IDNs can take to reduce drug spend, including finding clinical alternatives to overpriced drugs, centralizing inventory control, and using contracting to leverage better prices.
Learning Objectives:
1.  Demonstrate how pharmacy can help manage patient populations, especially through medication reconciliation.
2.  Evaluate ways that pharmacists can help reduce costly readmissions.
3.  Outline how drug price hyperinflation is harming IDNs’ bottom line, and what to do about it.
David A Kvancz MS, RPh FASHP
Senior Vice President, Strategic Client Relationships
Visante, Inc.

Theme 2:  Retooling Pharmacy Operations
Monday, April 16, 2018
3:10 PM - 3:45 PM
National Ballroom D
Managing pharmaceutical inventories across a multifaceted health system is costly and difficult.  Health systems are looking for new methods of data management, better technological inventory controls and improved logistics across their IDNs in order to save money, comply with increased regulatory mandates, decrease inventory turns, and improve access to care.
Since 2017, Greenville Health System has utilized the Greenville Pharmacy Consolidated Services Center to better manage their resources versus treating each acute care hospital as a stand-alone pharmacy. They’ll discuss how they put together a strategic business plan discovering how much the entire system was spending on pharmaceuticals and audited for pricing compliance. Eventually they demonstrated to senior leadership a business case with a compelling ROI to move forward with the project. After building-out an 8,000-square-foot distribution facility to centralize inventory, they begin the process of implementing these changes. 
You’ll discover their ROI, benchmarking metrics, issues with changing a culture engrained through years of ‘doing it one way’ and unintended consequences from changing to a centralized services center approach.
Learning Objectives:
1. Identify best practices to effectively manage pharmacy operations across a multi-site health system.
2. Describe the benefits that implementation of a pharmacy consolidated services center can provide.
3. Outline the challenges that must be addressed in the supply and regulation of pharmaceutical inventories.
William Matthew Parker PharmD, MHA, BCPS
Manager, Consolidated Pharmacy Services
Greenville Health System

Monday, April 16, 2018
4:00 PM - 4:40 PM
National Ballroom D
The role of the pharmacist in the ambulatory care setting is expanding as pharmacists in these facilities are providing a broad range of services, including conducting health and wellness testing, managing chronic illnesses, administering immunizations, and partnering with hospitals and health systems to improve overall health and wellness in order to reduce hospital readmissions.
In order to help patients manage costs, specifically Medicare Part D expenses, many ambulatory care pharmacists have implemented medication therapy management strategies.  These programs focus on improved education for patients, help prevent medication-related adverse events, save money for patients and providers, and empower patients to be actively involved in their health and wellness regimen.  
Learning Objectives:
1. Identify the types of patients who would benefit from the implementation of a medication therapy management plan.
2. Discuss ways that a medication therapy management plan can optimize a patient’s health.
3. Outline the core elements of a medication therapy management plan.
Teresa Elaine Roane PharmD, BCACP
Associate Director; Clinical Assistant Professor
Center for Quality Medication Management at the University of Florida

Monday, April 16, 2018
4:40 PM - 5:15 PM
National Ballroom D
The increasing cost and utilization of specialty medications, coupled with a rise in high-deductible health plans and cost-sharing strategies, is placing significant financial pressure on patients. Financial barriers may cause patients to be non-adherent to therapy, discontinue therapy early, or forego treatment entirely.  Specialty pharmacies are uniquely positioned to help maximize patient assistance through various manufacturer-sponsored and charitable programs. Robust use of these programs results in better patient care, positively impacting both patients and providers.
Learning Objectives:
1. Detail the factors causing uncertainty and financial hardship for pharmacy patients.
2. Identify three assistance programs that can help mitigate these burdens.
3. Discuss the impact these programs have on patients and providers.
Scott Sterrett PharmD
Manager, Specialty Pharmacy
Beaumont Health